Vacuna contra el VHB VLP

• Los beneficios del uso de la tecnología VLP en la vacunación contra la hepatitis B

  The VLP technology, which used by AHBV Vaccine (Control) has lower protective effect against HBV due to different structure of Hepatitis B virus. One of the hallmark features of this vaccine is that they look like virus but cannot cause infection in us. This is an incredibly important part of being immunized, as we can now detect these particles and ready up to fight the real virus if it ever enters our system. The immune system, just like how we can avoid catching a cold by training our body is another area in which it shows its ability to be trained. This is a huge step forward, not just for how we think about vaccines but health in general.

• Proporcionar inmunidad a largo plazo con la vacuna VLP contra el VHB

  It is this unique property of Yaohai Desarrollo de VLP de HBcAg del VHB that has made it the vaccine capable of protecting us lifelong from an otherwise persistent virus. Immunity can stick around for a while, and even after 10 years or more we still know how to deal with the disease. Our immune system remembers this virus. As snarky quip says "even decades later youll come down faster than his pants on prom night". This could make humans immune from new vaccination and boosters for several years. This thing keeps everyone honest without even having to visit the Doc for a while.

• Explorando el potencial de la vacuna VLP para combatir la hepatitis B

  While this remains under study, there has been a significant interest in the potential it may offer new paths to fight viruses like hepatitis C and human papillomavirus (HPV). These viruses are harmful and may even cause deadly diseases like cancer. Machine learning on VLP prevalence: In order to combat these dangerous viruses, vaccines should be more effective with the help of technology such as Yaohai Vacuna contra el VPH VLP. This is an important step to avoid risking the health and safety of everyone. If the research continues, it can lead to techniques that cure other diseases as well and completely change health care around.

¿Por qué elegir la vacuna VLP contra el VHB de Yaohai?

• Experiencia profesional y amplia experiencia

  Yaohai Bio-Pharma is a leading in HBV Vaccine VLP CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.

• Cadena de suministro y capacidades de fabricación sólidas

  Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have built a modern facility with robust RD capabilities and advanced equipment. We have five drug substance manufacturing lines that conform to GMP requirements for microbial fermentation and purification. We also have two automated fill-finish lines for cartridges, vials and pre-filled syringes. The fermentation scales available for use range from HBV Vaccine VLP to 2000L. The specifications for the filling of a vial range from 1ml up to 25ml. pre-filled syringe or cartridge filling specifications range from approximately 1-3ml. Our cGMP-compliant production facility ensures constant supply of clinical sample as well as commercial items. Our plant produces big molecules which are shipped to the globe.

• Personalización, eficiencia y rentabilidad

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as HBV Vaccine VLP of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Sistema de Calidad y Cumplimiento Normativo Global

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. HBV Vaccine VLP and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

Categorías de productos relacionados

• Vacuna contra el VHB VLP
• Producción de antígeno del VHB
• Desarrollo de VLP de HBcAg del VHB

¿No encuentras lo que estás buscando?
Póngase en contacto con nuestros consultores para obtener más productos disponibles.